
Enrique Diaz
@aediazmd
UT Health San Antonio - Mays Cancer Center. Hematologist-Oncologist with focus on Lymphomas and Health Care Disparities. Views are my own
ID: 1139343390926135301
14-06-2019 01:26:47
224 Tweet
155 Takipçi
198 Takip Edilen


My first month as an attending at UNMC Heme Onc has been an incredible experience, thanks to an amazing and welcoming team! Grateful to work alongside Julie Vose and everyone here (including the photobombers 😉)—Light The Night by The Leukemia & Lymphoma Society


First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL mdpi.com/3046102 #mdpicancers via Cancers MDPI Bench to bedside, a beautiful and highly rewarding journey @UTHealthSAMDA UT Health San Antonio Research The Leukemia & Lymphoma Society GELL_LATAM MDPI

👉FYI: ASCO election is now online! Please consider voting 🗳️ for Dr Jason Westin, MD FACP FASCO ! He is a world renowned physician-researcher in our heme/onc field, and Jason is a fierce advocate for our patients!! #lymsm #Leadership | Naveen Pemmaraju, MD Mike Thompson, MD, PhD, FASCO society.asco.org/about-asco/asc…


.UT Health San Antonio Multispecialty and Research Hospital dedication ushers in a ‘place of firsts.” Learn more 🔗: bit.ly/3V17bKz




“It’s a beautiful day to save lives” Patrick Dempsey Hem/Onc rounds with my rockstar visiting resident Anisha Agarwal UT Health SA Hematology/Oncology Fellowship @UTHealthSAMDA Hem-Onc Fellows Network



Congrats to our second-year Hem/Onc fellow Jay Parekh on his poster presentation at #AACR25 with Dr Mahadevan Ramesh @UTHealthSAMDA UT Health San Antonio Research Hem-Onc Fellows Network



From COO to Genetic Subtypes, and now Lymphoma Microenvironment Archetypes (LymphoMAPs) in DLBCL. #icml2025 Such an heterogeneous disease for which newest therapies are a must Mays Cancer Center at UT Health San Antonio clinicaltrials.gov/study/NCT06977….


Pretty pleased #icml2025 hearing Mark Roschewski re importance of thinking outside the box. More to come Mays Cancer Center at UT Health San Antonio with our upcoming CT for treatment naive DLBCL. clinicaltrials.gov/study/NCT06977…


Promising early data from LOTIS7 presented by Juan P. Alderuccio #18icml highlighting synergy of this BSpAb+ADC combination. Inclusive eligibility criteria (prior ASCT, CART allowed, proof of CD19/20 status not required). Looking forward to more data.


The future is here #ICML2025 Mays Cancer Center at UT Health San Antonio Marvelous benefit for patients and clinicians caring for DLBCL patients


Here are the top 10 trials from the 18th International Conference on Malignant Lymphoma (International Conference on Malignant Lymphoma 2025). Explore data and insights #ICML2025: t.ly/dz8T1 #LARVOL #Hematology #Lymphoma #CancerResearch #Oncology #CancerData #OncologyInsights #18ICML | Graham Collins |


Welcome to our first-year hem/onc fellows! Day #1 on the hematology and oncology inpatient services with our amazing attendings Marcela Mazo MD and Enrique Diaz ! Mays Cancer Center at UT Health San Antonio UT Health San Antonio Research Stephanie A. Haddad, DO


First year fellows learning how to perform bone marrow biopsies at didactics on Friday! Mays Cancer Center at UT Health San Antonio UT Health San Antonio Research Hem-Onc Fellows Network Anum Jalil Oscar Andre Hinojosa Castro Colton Jones
